“Shall Be the Property” Is Insufficient to Automatically Assign Title to an Invention in a Contract READ MORE
Haug Partners Secures Significant Win at the Delaware Chancery Court in Dispute Involving Cancer Drug Shortage READ MORE
Can Biologics Manufacturers Face Antitrust Risk For Pointing Out That Biosimilars Are Different? READ MORE
